Laurion Capital Management »

Fulcrum Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 145k 9.44
2023-12-31 $977k 145k 6.75
2023-06-30 $111k 34k 3.30
2019-12-31 $558k 34k 16.63
2019-09-30 $629k 95k 6.64

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
FMR
Cowen And Company
Suvretta Capital Management
Vanguard Group
Trv Gp Iv
Caption Management
BlackRock
Citadel Advisors
Dimensional Fund Advisors
Morgan Stanley
Leucadia National Corporation
MPM Oncology Impact Management
Adage Capital Partners GP
Logos Global Management

View all funds holding Fulcrum Therapeutics